From: Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis
Bivariate meta-regression model | |||
---|---|---|---|
Studies characteristics | Leucopenia | ||
 | Res. | Coeff. (CI 95%) | P |
Mean age | 0% | 0.99 (0.96 to 1.01) | 0.279 |
Previous treatment | Â | 1.59 (0.91 to 2.78) | 0.084 |